Variations of BRAF mutant allele percentage in melanomas.

Variations of BRAF mutant allele percentage in melanomas.
复制标题

DOI:
10.1186/s12885-015-1515-3
复制
发表时间:
2015-07-04
期刊:
影响因子:
3.8
通讯作者:
Emile JF
Emile JF
中科院分区:
医学2区
文献类型:
--
作者:
Hélias-Rodzewicz Z;Funck-Brentano E;Baudoux L;Jung CK;Zimmermann U;Marin C;Clerici T;Le Gall C;Peschaud F;Taly V;Saiag P;Emile JF

文献摘要

参考文献

被引文献

相似文献

BRAF突变存在于40%的人类皮肤黑色素瘤中。BRAF突变等位基因百分比(BRAF-M%)增加的突变肿瘤可能对RAF/MEK抑制剂有更好的反应。我们评估了黑色素瘤的BRAF-M%及其变异的遗传原因。通过焦磷酸测序、实时PCR(rtPCR)和/或皮升液滴PCR(dPCR)定量BRAF-M%。免疫组化法检测BRAF突变体的表达。用荧光原位杂交(FISH)和单核苷酸多态性(SNP)阵列分析染色体改变。焦磷酸测序获得的BRAF-M%定量与rtPCR和dPCR高度相关(R = 0.94)。从DNA和RNA定量的BRAF-M%也高度相关(R = 0.98)。在具有> 80%肿瘤细胞的368个样品中,38.6%具有BRAFV 600 E突变。仅66.2%的病例为杂合子(BRAF-M% 30 - 60%)。在19%的病例中观察到BRAF-M%增加(> 60%)。FISH显示BRAF野生型、杂合型和非杂合型BRAF突变样品中7号染色体的多体性分别为13.6%、35.3%和54.5%(P < 0.005)。BRAF基因座扩增(5.6%)和丢失(3.2%)少见.相比之下,在27/27例BRAF突变痣中,7号染色体为二体。BRAF-M%是异质性的,并且在BRAF突变型黑色素瘤中经常增加。7号染色体的非整倍体在BRAF突变型黑色素瘤中更常见,特别是在BRAF-M%高的黑色素瘤中。本文的在线版本(doi:10.1186/s12885-015-1515-3)包含补充材料,可供授权用户使用。
BRAF mutations are present in 40 % of human skin melanomas. Mutated tumors with an increased percentage of BRAF mutant alleles (BRAF-M%) may have a better response to RAF/MEK inhibitors. We evaluated the BRAF-M% in melanomas, and the genetic causes of its variation. BRAF-M% was quantified by pyrosequencing, real-time PCR (rtPCR) and/or picoliter-droplet PCR (dPCR). BRAF mutant expression was detected by immunohistochemistry. Chromosomal alterations were analyzed with fluorescence in situ hybridization (FISH), and single nucleotide polymorphism (SNP) arrays. BRAF-M% quantification obtained with pyrosequencing was highly correlated (R = 0.94) with rtPCR, and with dPCR. BRAF-M% quantified from DNA and RNA were also highly correlated (R = 0.98). Among 368 samples with >80 % tumor cells, 38.6 % had a BRAFV600E mutation. Only 66.2 % cases were heterozygous (BRAF-M% 30 to 60 %). Increased BRAF-M% (>60 %) was observed in 19 % of cases. FISH showed a polysomy of chromosome 7 in 13.6 %, 35.3 % and 54.5 % of BRAF wild-type, heterozygous and non-heterozygous BRAF-mutated samples, respectively (P < 0.005). Amplification (5.6 %) and loss (3.2 %) of BRAF locus were rare. By contrast, chromosome 7 was disomic in 27/27 BRAF-mutated nevi. BRAF-M% is heterogeneous and frequently increased in BRAF-mutant melanomas. Aneuploidy of chromosome 7 is more frequent in BRAF mutant melanomas, specifically in those with high BRAF-M%. The online version of this article (doi:10.1186/s12885-015-1515-3) contains supplementary material, which is available to authorized users.
DOI: 10.1038/sj.onc.1210252
发表时间: 2007-07-12
期刊: ONCOGENE
影响因子: 8
作者:
Joensson, G.;Dahl, C.;Borg, A.
通讯作者: Borg, A.
DOI: 10.1002/gcc.20785
发表时间: 2010-08-01
影响因子: 3.7
作者:
Gast, Andreas;Scherer, Dominique;Kumar, Rajiv
通讯作者: Kumar, Rajiv
DOI: 10.5858/arpa.2013-0031-oa
发表时间: 2014-01-01
影响因子: 4.6
作者:
Marin, Cristi;Beauchet, Alain;Emile, Jean-Francois
通讯作者: Emile, Jean-Francois
DOI: 10.1111/j.0022-202x.2005.23788.x
发表时间: 2005-08-01
影响因子: 6.5
作者:
Akslen, LA;Angelini, S;Kumar, R
通讯作者: Kumar, R
DOI: 10.1530/erc-14-0147
发表时间: 2014-12-01
影响因子: 3.9
作者:
Kim, Min-Hee;Bae, Ja Seong;Jung, Chan Kwon
通讯作者: Jung, Chan Kwon